BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38108527)

  • 41. [Fertility-preserving treatment outcomes in endometrial cancer and atypical hyperplasia patients with different molecular profiles].
    Shao WY; Dong YT; Lyu QY; Liao JB; Xue Y; Chen XJ
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):742-754. PubMed ID: 37849255
    [No Abstract]   [Full Text] [Related]  

  • 42. Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia.
    Fan Y; Li X; Wang J; Wang Y; Tian L; Wang J
    Reprod Biol Endocrinol; 2021 Aug; 19(1):118. PubMed ID: 34344384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia].
    Gong Q; Chen X; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia.
    Zhang Y; Li D; Yan Q; Song X; Tian W; Wang Y; Teng F; Wei L; Wang J; Zhang H; Xue F
    Cancer Manag Res; 2021; 13():5711-5722. PubMed ID: 34285588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hysteroscopic treatments for endometrial malignancies and premalignancies: state of the art.
    Kahramanoglu I
    Minim Invasive Ther Allied Technol; 2021 Oct; 30(5):272-277. PubMed ID: 34289318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The optimal time for the initiation of in vitro fertilization and embryo transfer among women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertility-sparing treatment.
    Song Z; Liu H; Zhou R; Xiao Z; Wang J; Wang H; Lu Q
    Arch Gynecol Obstet; 2022 May; 305(5):1215-1223. PubMed ID: 34762188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The results of different fertility-sparing treatment modalities and obstetric outcomes in patients with early endometrial cancer and atypical endometrial hyperplasia: Case series of 30 patients and systematic review.
    Piatek S; Michalski W; Sobiczewski P; Bidzinski M; Szewczyk G
    Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():139-147. PubMed ID: 34214800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of pregnancy outcome after fertility-preserving treatment among women with atypical endometrial hyperplasia or endometrial carcinoma].
    Xiao ZR; Lu Q; Zhou R; Wang YQ; Liang WY; Liu HX; Tang HR; Wu GZ; Liu XS; Zhang H; Ren Y; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):857-864. PubMed ID: 33355761
    [No Abstract]   [Full Text] [Related]  

  • 49. Fertility-Sparing Treatment of Patients with Endometrial Cancer: A Review of the Literature.
    Leone Roberti Maggiore U; Khamisy-Farah R; Bragazzi NL; Bogani G; Martinelli F; Lopez S; Chiappa V; Signorelli M; Ditto A; Raspagliesi F
    J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and early endometrial cancer to conservative treatment.
    Travaglino A; Raffone A; Gencarelli A; Micheli M; Franco L; Zullo F; Mollo A; Di Spiezio Sardo A; Bifulco G; Insabato L
    Int J Gynaecol Obstet; 2022 Sep; 158(3):742-747. PubMed ID: 34837386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.
    Kudesia R; Singer T; Caputo TA; Holcomb KM; Kligman I; Rosenwaks Z; Gupta D
    Am J Obstet Gynecol; 2014 Mar; 210(3):255.e1-4. PubMed ID: 24211482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral and intrauterine progestogens for atypical endometrial hyperplasia.
    Luo L; Luo B; Zheng Y; Zhang H; Li J; Sidell N
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009458. PubMed ID: 30521671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
    Yang B; Xu Y; Zhu Q; Xie L; Shan W; Ning C; Xie B; Shi Y; Luo X; Zhang H; Chen X
    Gynecol Oncol; 2019 Apr; 153(1):55-62. PubMed ID: 30674421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
    Leone Roberti Maggiore U; Martinelli F; Dondi G; Bogani G; Chiappa V; Evangelista MT; Liberale V; Ditto A; Ferrero S; Raspagliesi F
    J Gynecol Oncol; 2019 Jul; 30(4):e57. PubMed ID: 31074240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conservative Surgery in Endometrial Cancer.
    Gallo A; Catena U; Saccone G; Di Spiezio Sardo A
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T; Farrant C; Wise MR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of coexisting endometrial carcinoma in case of atypical endometrial hyperplasia diagnosed on total hysteroscopic resection.
    Pivano A; Crochet P; Carcopino X; Cravello L; Boubli L; Agostini A
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():210-3. PubMed ID: 27343737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maintenance Therapy Can Improve the Oncologic Prognosis and Obstetrical Outcome of Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer After Fertility-Preserving Treatment: A Multicenter Retrospective Study.
    He Y; Wang J; Wang Y; Zhou R; Lu Q; Liu G; Tang H; Guo H; He M; Wu G
    Front Oncol; 2021; 11():808881. PubMed ID: 34976844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology.
    Ushijima K; Tsuda N; Yamagami W; Mitsuhashi A; Mikami M; Yaegashi N; Enomoto T
    J Gynecol Oncol; 2023 May; 34(3):e38. PubMed ID: 36659833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fertility preservation in early-stage endometrial cancer and endometrial intraepithelial neoplasia: A single-center experience.
    Ayhan A; Tohma YA; Tunc M
    Taiwan J Obstet Gynecol; 2020 May; 59(3):415-419. PubMed ID: 32416890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.